Correspondence Influenza vaccination and prevention of cardiovascular disease mortality
Catharine Paules and Kanta Subbarao presented in their Seminar (Aug 12, 2017, p 697) the clinical features, therapeutic options, and controversies regarding treatment and prevention of seasonal influenza infection.1 Although they acknowledged that influenza can impair different organ systems, little attention was given to cardiovascular consequences. Ischaemic heart disease is the leading cause of death worldwide and influenza vaccination could reduce cardiovascular mortality, particularly in patients with coronary heart disease for whom cardiovascular mortality risk has been reported to be halved by influenza vaccination.
Outbreaks across the continent infected 21,000 and killed at least 35 people. Now governments are moving to make vaccinations mandatory.
Conclusions: Patients with nonhematological malignancies who are receiving chemotherapy mount an immune response to influenza vaccination. Timing of influenza vaccination in relation to chemotherapy does not seem to matter.
We examined early, late, and race-specific trends in cancer incidence, and calculated the estimated number of cancers prevented over the past 3 decades. Results: From 1976 to 2009, there was a significant decrease in the incidence of early-stage cervical cancer, from 9.8 to 4.9 cases per 100,000 women (P
Response to Comment on "γδ T Cells Are Required for the Induction of Sterile Immunity during Irradiated Sporozoite Vaccinations". J Immunol. 2018 Mar 01;200(5):1533-1534 Authors: Zaidi I, Duffy PE PMID: 29463688 [PubMed - in process]
Comment on "γδ T Cells Are Required for the Induction of Sterile Immunity during Irradiated Sporozoite Vaccinations". J Immunol. 2018 Mar 01;200(5):1533 Authors: McKenna KC, Tsuji M PMID: 29463687 [PubMed - in process]
We report of high influenza B Victoria virus prevalence in the 2015-16 winter season in Israel, affecting approximately half of the Israeli population. We further show that the Victoria B virus infected individuals of all ages and that it was present in the country throughout the entire winter season. The vaccine however included the inappropriate Yamagata virus. We propose that a quadrivalent vaccine, that includes both Yamagata and Victoria lineages, should be considered for future influenza vaccination. PMID: 29464098 [PubMed]
Evidence has shown an association between influenza infection and acute myocardial infarction. Should influenza vaccination be a routine part of coronary heart disease risk management?Heart
This report presents results for all 50 states, the District of Columbia, participating U.S. territories that include the Commonwealth of Puerto Rico (Puerto Rico) and Guam, 187 Metropolitan/Micropolitan Statistical Areas (MMSAs), and 210 counties (n = 475,687 survey respondents) for the year 2012. RESULTS: In 2012, the estimated prevalence of health-risk behaviors, chronic diseases or conditions, access to health care, and use of preventive health services substantially varied by state and territory, MMSA, and county. The following portion of the abstract lists a summary of results by selected BRFSS measures. Each se...
While the cure for cancer has been elusive, President Obama's National Cancer Moonshot initiative offers renewed hope that we could see breakthroughs in prevention, detection, and treatment for a disease that affects millions of Americans and their families. The cancer moonshot is the latest demonstration that Washington understands the potential for medical research to change lives and improve the health of all Americans. It builds on the bipartisan support we saw last fall when House and Senate negotiators agreed on a $2 billion budget increase for medical research through the National Institutes of Health (NIH). Today,...
Abstract Flu risk and burden much higher than assumed: Each year, influenza affects hundreds of millions of people. In order to limit the burden, influenza should remain at the top of the public health priority list. But influenza has attracted less attention recently and priorities and perceptions now differ around the globe, varying with the different cultural and economical contexts. For example, priorities in less-developed countries differ from those in developed countries. For this reason, every approach for raising awareness needs to be tailor-made, capable of responding to every specific stakeholder contex...